Animal tuberculosis (TB) attributable to Mycobacterium tuberculosis complicated (MTC) micro organism stays as some of the vital infectious ailments of livestock, regardless of a long time of eradication applications and analysis efforts, in an period the place the livestock sector is amongst a very powerful and quickly increasing industrial agricultural segments worldwide. This work offers a worldwide overview of the spatial and temporal tendencies of reported scientific data of TB in livestock, aiming to achieve insights into analysis subtopics throughout the animal TB epidemiology area and to focus on territorial inequalities concerning information reporting and analysis outputs over time. To ship such data, peer-reviewed studies of TB research in livestock had been retrieved from the Internet of Science and Google Scholar, systematized, and dissected.
The validated dataset contained 443 prevalence observations, protecting the 1981-2020 interval (39 years). We spotlight a transparent transfer in the direction of transdisciplinary areas and the One Well being method, with a worldwide temporal improve of publications combining livestock with wildlife and/or human parts, which replicate the significance of non-prototypical hosts as key to understanding animal TB. It turns into evident that cattle is the principle host throughout works from all continents, nonetheless many areas stay poorly surveyed.
Read Latest Articles: https://www.tbdb.org/how-accurate-are-covid-19-pcr-tests/
TB analysis in livestock in low-/middle-income international locations is markedly rising, reflecting modifications in animal husbandry, but in addition mirroring the globalization period, with a marked improve in worldwide collaboration and capacitation applications for scientific and technological improvement. This overview offers an outline of probably the most prolific continents, international locations, and analysis fields in animal TB epidemiology, clearly outlining data gaps and key precedence subjects. The estimated development pattern of livestock manufacturing till 2050, notably in Asia and Africa, in response to human inhabitants development and animal-protein demand, would require additional funding in early surveillance and adaptive analysis to accommodate the upper range of livestock species and MTC members and elevating the likelihood to finetune funding schemes.
Can a tuberculosis analysis program promoted by a scientific society contribute to the management of the illness?
Though Spain is a developed nation, Tuberculosis (TB) was for years a illness with excessive incidence charges in comparison with different European international locations, a state of affairs that worsened with the HIV/AIDS epidemic and with the rise of immigration. The Spanish Respiratory Society (SEPAR) created in 2004 the Built-in Analysis Applications (PII) on respiratory ailments, together with TB (PII-TB) which has carried out research associated to the 5 traces of analysis that it maintains: medical / epidemiological, microbiological, technological/medical administration, evaluative, and worldwide cooperation.
Following the suggestions on the need to guage well being applications made by worldwide organizations, the analysis of PII-TB was not too long ago carried out, revealing the state of affairs of the principle variables of the illness and their evolution over the time that this system has been working. PII-TB has generated considerable information on the state of affairs of this illness in our nation in years when this data has been restricted. The truth that the outcomes of the research have been extensively disseminated makes it simpler for all professionals concerned within the prevention, prognosis and remedy of TB to implement and/or to enhance actions that, lastly, will contribute to the management of this illness.
A pesar de que España es un paÃs desarrollado, la tuberculosis (TB) fue durante años una enfermedad con importantes tasas de incidencia con respecto a otros paÃses europeos, situación que empeoró con la epidemia del VIH/SIDA y el aumento de la inmigración. Como consecuencia de la situación, SEPAR crea en el año 2004 los Programas Integrados de Investigación (PII), entre los que se incluye la TB (PII-TB). Dicho programa ha llevado a cabo estudios relacionados con alguna de las cinco lÃneas de investigación que éste mantiene: clÃnica/epidemiológica, microbiológica, tecnológica/gestión clÃnica, evaluativa y de cooperación internacional.
Siguiendo las recomendaciones sobre la necesidad de evaluar los programas de salud que hacen los organismos internacionales, se realizó recientemente la evaluación del PII-TB, lo que ha permitido conocer la situación de las principales variables de la enfermedad a lo largo de los años de funcionamiento del programa y la evolución de las mismas. El PII-TB ha generado abundantes datos sobre la situación de esta enfermedad en nuestro paÃs durante unos años en que esta información ha sido limitada. El hecho de que los resultados de los estudios hayan sido extensamente difundidos, facilita que todos los profesionales implicados en la prevención, diagnóstico y tratamiento de la TB puedan implementar y/o mejorar last actividades que, en definitiva, contribuirán a mejorar el management de esta enfermedad.
Superior imaging instruments for childhood tuberculosis: potential purposes and analysis wants
Tuberculosis is the main explanation for loss of life globally that is because of a single pathogen, and as much as a fifth of sufferers with tuberculosis in high-incidence international locations are youngsters youthful than 16 years. Sadly, the prognosis of childhood tuberculosis is difficult as a result of the illness is commonly paucibacillary and it’s troublesome to acquire appropriate specimens, inflicting poor sensitivity of at the moment accessible pathogen-based checks.
Chest radiography is essential for diagnostic evaluations as a result of it detects abnormalities per childhood tuberculosis, however a number of limitations exist within the interpretation of such outcomes. Subsequently, different imaging strategies have to be systematically evaluated in youngsters with tuberculosis, though present information counsel that when accessible, cross-sectional imaging, comparable to CT, needs to be thought-about within the diagnostic analysis for tuberculosis in a symptomatic youngster.
Moreover, a lot of the understanding of childhood tuberculosis stems from medical specimens that may not precisely signify the lesional biology at an infection websites. By offering non-invasive measures of lesional biology, superior imaging instruments might improve the understanding of fundamental biology and enhance on the poor sensitivity of present pathogen detection methods.
Crassostrea gigas A-kinase anchor protein 7 isoform X2 |
1-CSB-EP2586DXQ(M)f1 |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Crassostrea gigas A-kinase anchor protein 7 isoform X2 expressed in E.coli |
Monoclonal Anti-M. tuberculosis Heat Shock Protein 65 (hsp65/groEL-2/Cpn60-2) IgG |
HSP651-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Mycobacterium tuberculosis (M. tuberculosis) Antibody |
abx415707-1ml |
Abbexa |
1 ml |
EUR 727.2 |
|
Recombinant Mycobacterium Tuberculosis HSP Protein |
VAng-Yyj0063-10g |
Creative Biolabs |
10 µg |
EUR 2250 |
Description: Mycobacterium Tuberculosis, HSP, recombinant protein. |
Monoclonal Anti-M. tuberculosis 10 Kda cultural filtrate protein (CFP10) IgG |
CFP101-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Monoclonal Anti-M. tuberculosis Rv1734 dormant protein from H37Rv strain IgG |
RV17341-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Monoclonal Anti-M. tuberculosis Rv2031 dormant protein from H37Rv strain IgG |
RV20311-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Monoclonal Anti-M. tuberculosis Rv2623 dormant protein from H37Rv strain IgG |
RV26231-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Monoclonal Anti-M. tuberculosis 10 Kda cultural filtrate protein (CFP10) IgG #2 |
CFP102-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Monoclonal Anti-M. tuberculosis Heat Shock Protein 70 (hsp70/Dnak/ML2496) IgG |
HSP701-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Mycobacterium tuberculosis HSP 70 Recombinant Protein |
53-349 |
ProSci |
0.01 mg |
EUR 789.9 |
Description: Mycobacterium tuberculosis HSP 70 Recombinant Protein |
M. Tuberculosis HSP70 Protein |
abx060544-100ug |
Abbexa |
100 ug |
EUR 1378.8 |
|
M. tuberculosis CFP10, Protein |
abx061400-100ug |
Abbexa |
100 ug |
EUR 961.2 |
|
M. tuberculosis ESAT6, Protein |
abx061402-100ug |
Abbexa |
100 ug |
EUR 910.8 |
|
Recombinant Myobacterium Tuberculosis Heat Shock Protein 65 |
7-07048 |
CHI Scientific |
2µg |
Ask for price |
Recombinant Myobacterium Tuberculosis Heat Shock Protein 65 |
7-07049 |
CHI Scientific |
10µg |
Ask for price |
Recombinant Myobacterium Tuberculosis Heat Shock Protein 65 |
7-07050 |
CHI Scientific |
100µg |
Ask for price |
Myobacterium Tuberculosis Heat Shock Protein 65 Protein |
20-abx263477 |
Abbexa |
-
EUR 2047.20
-
EUR 393.60
-
EUR 276.00
|
|
|
Anti-Acr1 (M. tuberculosis) Purified |
11-185-C100 |
ExBio |
0.1 mg |
EUR 244.8 |
Anti-Tb10.4 (M. tuberculosis) Purified |
11-186-C100 |
ExBio |
0.1 mg |
EUR 244.8 |
Anti-Tb10.3 (M. tuberculosis) Purified |
11-187-C100 |
ExBio |
0.1 mg |
EUR 244.8 |
Anti-Acr2 (M. tuberculosis) Purified |
11-188-C100 |
ExBio |
0.1 mg |
EUR 244.8 |
Anti-Ag85b (M. tuberculosis) Purified |
11-189-C100 |
ExBio |
0.1 mg |
EUR 244.8 |
Anti-Tb7.7 (M. tuberculosis) Purified |
11-190-C100 |
ExBio |
0.1 mg |
EUR 244.8 |
Anti-GlcB (M. tuberculosis) Purified |
11-192-C100 |
ExBio |
0.1 mg |
EUR 244.8 |
M. Tuberculosis 38 kDa Protein |
abx060636-100ug |
Abbexa |
100 ug |
EUR 978 |
|
Zmp1 M. tuberculosis Recombinant Protein |
90-361 |
ProSci |
50 ug |
EUR 752.1 |
Description: M13 endopeptidases are single-pass, transmembrane zinc-metallopeptidases responsible in human for the regulation of the biological activity of many hormones and peptides and are involved in many important processes such as blood pressure regulation (Neprilysin or NEP1), cardiovascular development (Endothelin Converting Enzyme-1 or ECE-12), prevention of haemolytic reaction (KELL) and phosphate homeostasis (PHEX). Zmp1 is a soluble enzyme member of the M13 endopeptidases family that plays a key role in Mycobacterium tuberculosis pathogenicity with a still unknown mechanism. Recently, it was shown to suppress inflammasome activation by inhibiting caspase-1 activation, thus preventing processing of pro-IL-1beta into IL-1beta and the consequent phagosome maturation. |
Ubiquitin 2 (Ub2, 65-76) peptide with anti-M. tuberculosis activity (STLHLVLRLRGG, MW:1321.6) |
UBQ151-P |
Alpha Diagnostics |
1 mg |
EUR 182.4 |
Recombinant Mycobacterium Tuberculosis rpmD Protein (aa 1-65) |
VAng-Yyj0608-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 1562.4 |
Description: Mycobacterium Tuberculosis 50S ribosomal protein L30 (rpmD), recombinant protein. |
Rabbit polyclonal antibody for M. tuberculosis |
4603 |
Virostat |
1 ml |
EUR 360.16 |
Description: This is FITC conjugated rabbit polyclonal antibody against M tuberculosis all antigens for WB, ELISA. |
Rabbit polyclonal antibody for M. tuberculosis |
4607 |
Virostat |
1 ml |
EUR 360.16 |
Description: This is Biotin conjugated rabbit polyclonal antibody against M tuberculosis all antigens for WB, ELISA. |
Mouse antibody for M. tuberculosis CFP10 |
5172 |
Virostat |
100 ug |
EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against M tuberculosis CFP10 for WB, ELISA. |
Mouse antibody for M. tuberculosis ESAT6 |
5173 |
Virostat |
100 ug |
EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against M tuberculosis ESAT6 for WB, ELISA. |
Mouse antibody for M. tuberculosis 38kDa |
5174 |
Virostat |
100 ug |
EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against M tuberculosis 38kDa for WB, ELISA. |
Mouse antibody for M. tuberculosis Hsp65 |
5177 |
Virostat |
100 ug |
EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against M tuberculosis Hsp65 for WB, ELISA. |
Mouse antibody for M. tuberculosis Hsp65 |
5178 |
Virostat |
100 ug |
EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against M tuberculosis Hsp65 for WB, ELISA. |
Anti-CFP-10 (M. tuberculosis) Purified |
11-490-C025 |
ExBio |
0.025 mg |
EUR 146.4 |
Anti-CFP-10 (M. tuberculosis) Purified |
11-490-C100 |
ExBio |
0.1 mg |
EUR 244.8 |
Anti-ESAT-6 (M. tuberculosis) Purified |
11-491-C025 |
ExBio |
0.025 mg |
EUR 146.4 |
Anti-ESAT-6 (M. tuberculosis) Purified |
11-491-C100 |
ExBio |
0.1 mg |
EUR 244.8 |
Rabbit polyclonal antibody for M. tuberculosis |
304 |
Virostat |
1 ml |
EUR 386.26 |
Description: This is HRP conjugated rabbit polyclonal antibody against M tuberculosis all antigens for WB, ELISA. |
M. tuberculosis 38 kDa recombinant antigen |
8811 |
Virostat |
100 ug |
EUR 477.6 |
Description: This is M. tuberculosis 38 kDa recombinant antigen for ELISA,WB. |
NAD Kinase M. tuberculosis Recombinant Protein |
90-365 |
ProSci |
50 ug |
EUR 651.3 |
Description: NAD kinase catalyzes the transfer of a phosphate group from ATP to NAD+ to generate NADP+, which in its reduced form acts as an electron donor for biosynthetic reactions. NADP+ is an essential coenzyme in metabolism and provides reducing power to biosynthetic processes such as fatty acid biosynthesis. NAD kinase from Mycobacterium tuberculosis is not ATP-dependent but has a broader substrate specificity than human NAD kinase. It can economically produce NADP+ by using other nucleoside triphosphates as well as inorganic polyphosphate as a source of phosphorus. Was identified as a high-confidence drug target. Catalytic activity: ATP + NAD+ = ADP + NADP+ |
NAD Synthetase M. tuberculosis Recombinant Protein |
90-366 |
ProSci |
50 ug |
EUR 752.1 |
Description: NAD synthetase is an essential enzyme involved in both the de novo biosynthesis and salvage of NAD+, catalyzing the final step of both pathways. Since NAD has a vital role in cell metabolism, the enzyme represents a valid target for the development of new antimycobacterial agents. It can use both glutamine or ammonia as a nitrogen source. Catalytic activity: ATP + deamido-NAD+ + L-glutamine + H2O = AMP + diphosphate + NAD+ + L-glutamate |
M. Tuberculosis ClpP Protease Assay Kit |
TBP100K |
ProFoldin |
100 assays |
EUR 278.4 |
Description: This product includes 3100 ul of Assay Buffer and 310 ul of 10 x Substrate and 3500 ul of Stop solution. It is for 100 assays in 384-well plate format |
Mycobacterium tuberculosis 16 kDa Antigen (M. tuberculosis 16 kDa) Antibody |
abx415759-01mg |
Abbexa |
0.1 mg |
EUR 760.8 |
|
Mycobacterium tuberculosis 38 kDa Antigen (M. tuberculosis 38 kDa) Antibody |
abx411025-02mg |
Abbexa |
0.2 mg |
EUR 678 |
|
Recombinant purified M. tuberculosis Heat Shock Protein 65 (hsp65/groEL-2/Cpn60-2) control for Western |
HSP651-C |
Alpha Diagnostics |
100 ul |
EUR 343.2 |
Recombinant M. Tuberculosis CFP10: ESAT6 Chimera protein |
DAGA-193 |
Creative Diagnostics |
1 mg |
EUR 2042.4 |
Recombinant M. Tuberculosis EspC/Rv3615c(H37Rv) [His] |
DAGA-3055 |
Creative Diagnostics |
100ug |
EUR 764.4 |
Mouse antibody for M. tuberculosis 16 kDa |
5175 |
Virostat |
100 ug |
EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against M tuberculosis 16 kDa for WB, ELISA. |
Mouse antibody for M. tuberculosis 16 kDa |
5176 |
Virostat |
100 ug |
EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against M tuberculosis 16 kDa for WB, ELISA. |
Pyrroline-5-caroxylate reductase, M. tuberculosis Recombinant |
P1456-10 |
Biovision |
|
EUR 314.4 |
Pyrroline-5-caroxylate reductase, M. tuberculosis Recombinant |
P1456-50 |
Biovision |
|
EUR 1083.6 |
M. Tuberculosis ClpP Protease Assay Kit Plus |
TBP100KE |
ProFoldin |
100 assays |
EUR 467.15 |
Description: This product includes 3000 ul of Assay Buffer, 310 ul of 10 x Substrate, 3500 ul of Stop solution and 31 ul of 100 x Mtb ClpP1P2 protease. It is for 100 assays in 384-well plate format |
Monoclonal Anti-Mycobacterium tuberculosis antigen (16kDa/Hspx) IgG |
MTB161-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Monoclonal Anti-Mycobacterium tuberculosis antigen 38kDa/Ag85B IgG |
MTB381-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Mycobacterium tuberculosis Enoyl-[acyl-carrier-protein] reductase [NADH] (M. tuberculosis inhA) Antibody |
20-abx109426 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Mouse Anti-Mycobacterium tuberculosis Heat Shock Protein 65 Monoclonal Antibody |
DMAB3971-05mg |
Creative Diagnostics |
0.5 mg |
EUR 1162.8 |
Mouse Anti-Mycobacterium tuberculosis Heat Shock Protein 65 Monoclonal Antibody |
DMAB3971-1mg |
Creative Diagnostics |
1 mg |
EUR 1762.8 |
Monoclonal Anti-Mycobacterium tuberculosis antigen (6kDa/ESAT-6) IgG |
MTB061-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Recombinant M. tuberculosis Ag85B Protein, His, Yeast-100ug |
QP7004-ye-100ug |
EnQuireBio |
100ug |
EUR 945.6 |
Recombinant M. tuberculosis Ag85B Protein, His, Yeast-10ug |
QP7004-ye-10ug |
EnQuireBio |
10ug |
EUR 434.4 |
Recombinant M. tuberculosis Ag85B Protein, His, Yeast-1mg |
QP7004-ye-1mg |
EnQuireBio |
1mg |
EUR 3296.4 |
Recombinant M. tuberculosis Ag85B Protein, His, Yeast-200ug |
QP7004-ye-200ug |
EnQuireBio |
200ug |
EUR 1512 |
Recombinant M. tuberculosis Ag85B Protein, His, Yeast-500ug |
QP7004-ye-500ug |
EnQuireBio |
500ug |
EUR 2164.8 |
Recombinant M. tuberculosis Ag85B Protein, His, Yeast-50ug |
QP7004-ye-50ug |
EnQuireBio |
50ug |
EUR 576 |
Recombinant M. tuberculosis Ag85C Protein, His, E.coli-100ug |
QP7382-ec-100ug |
EnQuireBio |
100ug |
EUR 848.4 |
Recombinant M. tuberculosis Ag85C Protein, His, E.coli-10ug |
QP7382-ec-10ug |
EnQuireBio |
10ug |
EUR 391.2 |
Recombinant M. tuberculosis Ag85C Protein, His, E.coli-1mg |
QP7382-ec-1mg |
EnQuireBio |
1mg |
EUR 2763.6 |
Recombinant M. tuberculosis Ag85C Protein, His, E.coli-200ug |
QP7382-ec-200ug |
EnQuireBio |
200ug |
EUR 1338 |
Recombinant M. tuberculosis Ag85C Protein, His, E.coli-500ug |
QP7382-ec-500ug |
EnQuireBio |
500ug |
EUR 1816.8 |
Recombinant M. tuberculosis Ag85C Protein, His, E.coli-50ug |
QP7382-ec-50ug |
EnQuireBio |
50ug |
EUR 522 |
Recombinant M. tuberculosis INHA Protein, His, Yeast-100ug |
QP7385-ye-100ug |
EnQuireBio |
100ug |
EUR 945.6 |
Recombinant M. tuberculosis INHA Protein, His, Yeast-10ug |
QP7385-ye-10ug |
EnQuireBio |
10ug |
EUR 434.4 |
Recombinant M. tuberculosis INHA Protein, His, Yeast-1mg |
QP7385-ye-1mg |
EnQuireBio |
1mg |
EUR 3296.4 |
Recombinant M. tuberculosis INHA Protein, His, Yeast-200ug |
QP7385-ye-200ug |
EnQuireBio |
200ug |
EUR 1512 |
Recombinant M. tuberculosis INHA Protein, His, Yeast-500ug |
QP7385-ye-500ug |
EnQuireBio |
500ug |
EUR 2164.8 |
Recombinant M. tuberculosis INHA Protein, His, Yeast-50ug |
QP7385-ye-50ug |
EnQuireBio |
50ug |
EUR 576 |
Recombinant M. tuberculosis Ag85A Protein, His, E.coli-100ug |
QP8929-ec-100ug |
EnQuireBio |
100ug |
EUR 848.4 |
Recombinant M. tuberculosis Ag85A Protein, His, E.coli-10ug |
QP8929-ec-10ug |
EnQuireBio |
10ug |
EUR 391.2 |
Recombinant M. tuberculosis Ag85A Protein, His, E.coli-1mg |
QP8929-ec-1mg |
EnQuireBio |
1mg |
EUR 2763.6 |
Recombinant M. tuberculosis Ag85A Protein, His, E.coli-200ug |
QP8929-ec-200ug |
EnQuireBio |
200ug |
EUR 1338 |
Recombinant M. tuberculosis Ag85A Protein, His, E.coli-500ug |
QP8929-ec-500ug |
EnQuireBio |
500ug |
EUR 1816.8 |
Recombinant M. tuberculosis Ag85A Protein, His, E.coli-50ug |
QP8929-ec-50ug |
EnQuireBio |
50ug |
EUR 522 |
Mycobacterium tuberculosis Enoyl-[acyl-carrier-protein] reductase [NADH] (M. tuberculosis inhA) Antibody (HRP) |
20-abx109170 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Mycobacterium tuberculosis Enoyl-[acyl-carrier-protein] reductase [NADH] (M. tuberculosis inhA) Antibody (Biotin) |
20-abx106339 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Mycobacterium tuberculosis Enoyl-[acyl-carrier-protein] reductase [NADH] (M. tuberculosis inhA) Antibody (FITC) |
20-abx107752 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
HCG?Anti-Human Chorionic Gonadotrophin Antibody IgG) ELISA test |
65 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of HCG?Anti-Human Chorionic Gonadotrophin Antibody IgG) |
Mouse Monoclonal Anti-Zaire Ebola virus (killed) IgG (mixture of EVZ12-M and EVZ13-M), aff pure |
EVZ14-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Ammonium Bromide - 3 M (100ml) |
M-CSS-423 |
MiTeGen |
1 Unit |
EUR 85 |
|
Description: Ammonium Bromide - 3 M (100ml) |
Imidazole, 1 M (100 ml) |
M-CSS-512 |
MiTeGen |
4 x 25 ml |
EUR 79 |
|
Description: Imidazole, 1 M (100 ml) |
HSP antibody |
10R-10337 |
Fitzgerald |
100 ug |
EUR 522 |
Description: Mouse monoclonal HSP antibody |
HSP Antibody |
abx018126-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
IgG Antibody to M. Tuberculosis, TB-IgG ELISA Kit |
DEIA083 |
Creative Diagnostics |
96T |
EUR 676.8 |
Description: This kit is anenzyme-linked immunosorbent assay for qualitative detection of IgG antibodies to Mycobacterium tuberculosis in human serum or plasma. It is intended for diagnosing and monitoring of patients related to infection by M. tuberculosis and other Mycobacteria. |
Recombinant M. tuberculosis Ag85B Protein, His-SUMO, E.coli-100ug |
QP7004-ec-100ug |
EnQuireBio |
100ug |
EUR 848.4 |
Recombinant M. tuberculosis Ag85B Protein, His-SUMO, E.coli-1mg |
QP7004-ec-1mg |
EnQuireBio |
1mg |
EUR 2763.6 |
Recombinant M. tuberculosis Ag85B Protein, His-SUMO, E.coli-200ug |
QP7004-ec-200ug |
EnQuireBio |
200ug |
EUR 1338 |
Recombinant M. tuberculosis Ag85B Protein, His-SUMO, E.coli-500ug |
QP7004-ec-500ug |
EnQuireBio |
500ug |
EUR 1816.8 |
Recombinant M. tuberculosis Ag85B Protein, His-SUMO, E.coli-50ug |
QP7004-ec-50ug |
EnQuireBio |
50ug |
EUR 522 |
Recombinant M. tuberculosis INHA Protein, His-SUMO, E.coli-100ug |
QP7385-ec-100ug |
EnQuireBio |
100ug |
EUR 848.4 |
Recombinant M. tuberculosis INHA Protein, His-SUMO, E.coli-10ug |
QP7385-ec-10ug |
EnQuireBio |
10ug |
EUR 391.2 |
Recombinant M. tuberculosis INHA Protein, His-SUMO, E.coli-1mg |
QP7385-ec-1mg |
EnQuireBio |
1mg |
EUR 2763.6 |
Recombinant M. tuberculosis INHA Protein, His-SUMO, E.coli-200ug |
QP7385-ec-200ug |
EnQuireBio |
200ug |
EUR 1338 |
Recombinant M. tuberculosis INHA Protein, His-SUMO, E.coli-500ug |
QP7385-ec-500ug |
EnQuireBio |
500ug |
EUR 1816.8 |
Recombinant M. tuberculosis INHA Protein, His-SUMO, E.coli-50ug |
QP7385-ec-50ug |
EnQuireBio |
50ug |
EUR 522 |
Recombinant M. tuberculosis Antitoxin MT2731 Protein, His, Yeast-10ug |
QP9476-ye-10ug |
EnQuireBio |
10ug |
EUR 434.4 |
Recombinant M. tuberculosis Antitoxin MT2731 Protein, His, Yeast-1mg |
QP9476-ye-1mg |
EnQuireBio |
1mg |
EUR 3296.4 |
Recombinant M. tuberculosis Antitoxin MT2731 Protein, His, Yeast-200ug |
QP9476-ye-200ug |
EnQuireBio |
200ug |
EUR 1512 |
Recombinant M. tuberculosis Antitoxin MT2731 Protein, His, Yeast-500ug |
QP9476-ye-500ug |
EnQuireBio |
500ug |
EUR 2164.8 |
Recombinant M. tuberculosis Antitoxin MT2731 Protein, His, Yeast-50ug |
QP9476-ye-50ug |
EnQuireBio |
50ug |
EUR 576 |
1,6-Hexanediol, 5 M, 100 ML |
M-CSS-109 |
MiTeGen |
100 ml |
EUR 70 |
|
Description: 1,6-Hexanediol, 5 M, 100 ML |
Ammonium Acetate, 5 M, 100 ML |
M-CSS-129 |
MiTeGen |
100 ml |
EUR 70 |
|
Description: Ammonium Acetate, 5 M, 100 ML |
Ammonium Chloride, 5 M, 100 ML |
M-CSS-131 |
MiTeGen |
100 ml |
EUR 70 |
|
Description: Ammonium Chloride, 5 M, 100 ML |
Ammonium Fluoride, 10 M, 100 ML |
M-CSS-134 |
MiTeGen |
4 x 25 ml |
EUR 90 |
|
Description: Ammonium Fluoride, 10 M, 100 ML |
Ammonium Formate, 5 M, 100 ML |
M-CSS-136 |
MiTeGen |
100 ml |
EUR 108 |
|
Description: Ammonium Formate, 5 M, 100 ML |
Ammonium Iodide, 1 M, 100 ML |
M-CSS-137 |
MiTeGen |
100 ml |
EUR 108 |
|
Description: Ammonium Iodide, 1 M, 100 ML |
Ammonium Nitrate, 10 M, 100 ML |
M-CSS-138 |
MiTeGen |
100 ml |
EUR 90 |
|
Description: Ammonium Nitrate, 10 M, 100 ML |
Ammonium Sulfate, 4 M, 100 ML |
M-CSS-143 |
MiTeGen |
100 ml |
EUR 70 |
|
Description: Ammonium Sulfate, 4 M, 100 ML |
Cadmium Chloride, 1 M, 100 ML |
M-CSS-151 |
MiTeGen |
4 x 25 ml |
EUR 108 |
|
Description: Cadmium Chloride, 1 M, 100 ML |
Cadmium Sulfate, 1 M, 100 ML |
M-CSS-152 |
MiTeGen |
4 x 25 ml |
EUR 108 |
|
Description: Cadmium Sulfate, 1 M, 100 ML |
Cesium Chloride, 1 M, 100 ML |
M-CSS-157 |
MiTeGen |
100 ml |
EUR 108 |
|
Description: Cesium Chloride, 1 M, 100 ML |
Lithium Nitrate, 8 M, 100 ML |
M-CSS-204 |
MiTeGen |
4 x 25 ml |
EUR 108 |
|
Description: Lithium Nitrate, 8 M, 100 ML |
Lithium Sulfate, 2.5 M, 100 ML |
M-CSS-207 |
MiTeGen |
100 ml |
EUR 77 |
|
Description: Lithium Sulfate, 2.5 M, 100 ML |
Sodium Malonate, 2 M, 100 ML |
M-CSS-217 |
MiTeGen |
100 ml |
EUR 177 |
|
Description: Sodium Malonate, 2 M, 100 ML |
Potassium Acetate, 5 M, 100 ML |
M-CSS-262 |
MiTeGen |
100 ml |
EUR 77 |
|
Description: Potassium Acetate, 5 M, 100 ML |
Potassium Bromide, 4 M, 100 ML |
M-CSS-264 |
MiTeGen |
100 ml |
EUR 90 |
|
Description: Potassium Bromide, 4 M, 100 ML |
Potassium Formate, 10 M, 100 ML |
M-CSS-269 |
MiTeGen |
100 ml |
EUR 130 |
|
Description: Potassium Formate, 10 M, 100 ML |
Potassium Iodide, 1 M, 100 ML |
M-CSS-270 |
MiTeGen |
100 ml |
EUR 77 |
|
Description: Potassium Iodide, 1 M, 100 ML |
Potassium Nitrate, 1 M, 100 ML |
M-CSS-272 |
MiTeGen |
4 x 25 ml |
EUR 77 |
|
Description: Potassium Nitrate, 1 M, 100 ML |
Potassium Sulfate 0.5 M, 100 ML |
M-CSS-275 |
MiTeGen |
100 ml |
EUR 70 |
|
Description: Potassium Sulfate 0.5 M, 100 ML |
Potassium Thiocyanate, 2 M, 100 ML |
M-CSS-276 |
MiTeGen |
100 ml |
EUR 90 |
|
Description: Potassium Thiocyanate, 2 M, 100 ML |
Sodium Acetate, 2.5 M, 100 ML |
M-CSS-284 |
MiTeGen |
100 ml |
EUR 70 |
|
Description: Sodium Acetate, 2.5 M, 100 ML |
Sodium Bromide, 3 M, 100 ML |
M-CSS-285 |
MiTeGen |
100 ml |
EUR 70 |
|
Description: Sodium Bromide, 3 M, 100 ML |
Sodium Chloride, 5 M, 100 ML |
M-CSS-286 |
MiTeGen |
100 ml |
EUR 70 |
|
Description: Sodium Chloride, 5 M, 100 ML |
Sodium Fluoride, 1 M, 100 ML |
M-CSS-290 |
MiTeGen |
100 ml |
EUR 77 |
|
Description: Sodium Fluoride, 1 M, 100 ML |
Lastly, there are key data gaps concerning using imaging instruments for childhood tuberculosis that we outlined on this Private View, along with a proposed roadmap for future analysis.